It had been verified that NRP‐1/CD304 was a very useful and dependable marker for the MRD assessment of B‐ALL because it was overexpressed in B‐ALL cells compared with normal precursor B cells.27, 28, 29, 30. Here, NRP1 is linked to acute lymphoblastic leukemia.